Related Experiment Videos
[Treatment of disseminated sclerosis with beta-inferferon--why and why not?]
Ugeskrift for Laeger
|July 21, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Significance and stability of cerebrospinal fluid oligoclonal band patterns in multiple sclerosis.
Multiple sclerosis and related disorders·2025
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.
Multiple sclerosis and related disorders·2023
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis.
Journal of neuroimmunology·2019
Illegal cannabis use is common among Danes with multiple sclerosis.
Multiple sclerosis and related disorders·2019
Early versus later treatment start in multiple sclerosis: a register-based cohort study.
European journal of neurology·2018
[Myelin oligodendrocyte glycoprotein antibody-associated disease].
Ugeskrift for laeger·2026
[Clinical pharmacogenetics and the use of biobanks].
Ugeskrift for laeger·2026
[Cutaneous myiasis].
Ugeskrift for laeger·2026
[When radiology does not rule out intracranial hypertension].
Ugeskrift for laeger·2026
[Intracranial hypotension].
Ugeskrift for laeger·2026
[Large macrocystic lymphatic malformation in a newborn].
Ugeskrift for laeger·2026
Phloretin Modulates STING Ubiquitination Degradation to Restrain Dendritic Cell Overactivation and Alleviate Sjögren's Syndrome.
Pharmaceuticals (Basel, Switzerland)·2026